StockData
Trane Technologies plc logo

Trane Technologies plc (TT) stock analysis

TTNYSEAuto Controls For Regulating Residential & Comml EnvironmentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 23/3010% below fair value
$424.84+4.02 (+0.96%)

Close on Nov 11, 2026Market cap $93.00BP/E 30.0Yield 0.89%

StockData Score

Prices as of Nov 11, 2026How the score works

Value4Growth4Performance6Health5Dividend4

Strong23 of 30 checks passed

Trane Technologies passes 23 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
4/6
Growth
4/6
Past performance
6/6
Financial health
5/6
Dividend
4/6

What stands out

  • Trading below fair value

    The share price of $424.84 is below our fair value estimate of $473.33.

  • Return on equity over 15%

    Return on equity was 36.1% over the last twelve months and averaged 30.8% over five years.

  • Return on capital over 10%

    Return on invested capital was 25.0%, above the 10% that usually covers the cost of capital.

  • Earnings grew over 5 years

    Net income grew 27.8% a year on average over the last five fiscal years.

What to watch

  • Margin of safety under 20%

    The price is 10.2% below fair value, less than the 20% cushion we look for.

  • High debt

    Debt is 46.3% of shareholders' equity, above the 40% we consider low.

  • Earnings growth not accelerating

    Net income grew 7.5% over the last twelve months, against a 5-year average of 27.8% a year.

  • P/B above the industry

    Trane Technologies's price-to-book of 10.21 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

Valuation4/6
  • P/E below its 5-year median

    Trane Technologies's P/E of 30.0 is below its own 5-year median of 32.0.

  • P/E below the industry

    Trane Technologies's P/E of 30.0 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.

  • EV/EBITDA below its 5-year median

    Trane Technologies's EV/EBITDA of 21.3 is below its 5-year median of 22.2.

  • P/B above the industry

    Trane Technologies's price-to-book of 10.21 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

  • Trading below fair value

    The share price of $424.84 is below our fair value estimate of $473.33.

  • Margin of safety under 20%

    The price is 10.2% below fair value, less than the 20% cushion we look for.

Growth4/6
  • Revenue growing 10%+ a year

    Revenue grew 10.1% a year over the last three fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 20.2% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew 7.5% over the last twelve months, against a 5-year average of 27.8% a year.

  • Growing faster than the industry

    Revenue grew 10.3% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Guidance raised

    Trane Technologies raised its full-year 2026 organic revenue growth outlook on Jul 30, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance6/6
  • Return on equity over 15%

    Return on equity was 36.1% over the last twelve months and averaged 30.8% over five years.

  • Return on capital over 10%

    Return on invested capital was 25.0%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Trane Technologies's return on equity of 36.1% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

  • Earnings grew over 5 years

    Net income grew 27.8% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 13.6% over the last twelve months, against a 5-year average of 11.8%.

  • Net margin above the industry

    Trane Technologies's net margin of 13.6% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.

Financial health5/6
  • High debt

    Debt is 46.3% of shareholders' equity, above the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 82.3% five years ago to 46.3%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 99.3% of total debt.

  • Interest well covered

    Operating income covers interest expense 19.2 times.

  • Short-term assets cover short-term debts

    Current assets are 1.12 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 6.02; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Trane Technologies paid dividends worth 0.7% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.7% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Trane Technologies yields 0.7%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 28.6% of net income.

  • Covered by free cash flow

    Dividends take 23.6% of free cash flow.

Scores of similar companies

Our estimate per share

$473.33

The share price is 10% below this estimate.

20%+ below
Near fair value
20%+ above
$424.84Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E34.2×32.0×36.5×$484.6053%
EV/EBITDA23.0×22.2×23.7×$460.4647%
Earnings powerleft out, too far from the others10.6% cost of equity––$110.87–
Fair value$473.33100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 32.0
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$692.58M
Value traded per 1% price move
$424.11M

Downside

Low risk

Typical loss in a bad month
12.8%
Volatility (annualized)
30%
Sharpe ratio, 1 year
-0.21
Beta to the S&P 500 (5Y)
1.13

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

–

Operating margin

18.6%+6.3 pts over 5 years

Net margin

13.7%+6.8 pts over 5 years

See a number that looks wrong?